Condition
Stage IB Cervical Cancer FIGO 2018
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07196033Recruiting
Asian Gynecological Brachytherapy Registry in Cervical Cancer
NCT04574635Active Not Recruiting
Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer
NCT05722288Phase 2Recruiting
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
NCT05093712WithdrawnPrimary
Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy
Showing all 4 trials